Navigation Links
Sunscreen Lotions Offering High Protection May Be Better Than Usual Sunscreens

the same label (14 percent). In total, 63 participants experienced sunburn, with six of them having severe sunburn.

The findings do not support the hypothesis that a higher SPF induces a higher exposure by delaying the alarm signs or the hypothesis that mentioning ‘high protection’ on the label may induce longer exposure by giving an impression of safety. The study logically confirms that the use of higher-SPF sunscreens does reduce the number of sunburns in real life. The results also suggest that people tend to self-regulate their sun protection with sunscreens, by inversely adapting the amount of sunscreen to the SPF, at least when sunscreens are freely delivered.

Source: Newswise


'"/>




Page: 1 2

Related medicine news :

1. Use Of Sunscreen In Childhood And Prevents Future Skin Cancer
2. People Still Neglect To Use Sunscreen In Spite Of Cancer Warnings
3. Lawsuit Against Sunscreen Makers For False Claims of Protection Against Skin Cancer
4. Lifting The Screen off Misleading Sunscreen labels
5. Use of Nanoparticles in Sunscreen under Scrutiny
6. How Effective Is Your Sunscreen?
7. Sunscreen Blocking UVA Radiation Receives Federal Approval
8. Improper Usage Of Sunscreen Can Harm Skin
9. Sunscreen creams – use them appropriately
10. More Sunscreen, Please
11. Sunscreen Covering Earth Becoming Thinner
Post Your Comments:
(Date:7/30/2014)... York, New York (PRWEB) July 30, 2014 ... morcellators ( http://www.injurybeacon.com/power-morcellator/ ) in gynecological surgeries continues to ... added her voice to those calling for a ban ... in Denver, Debra Valverde was diagnosed with leiomyosarcoma following ... morcellator. Within a year of her diagnosis, the aggressive ...
(Date:7/30/2014)... Hospitals continually face the challenge of ... their practitioners provide. During a recent AllMed webinar, ... importance of establishing effective peer review practitioner evaluation ... of care. , With regard to best ... on setting performance expectations, conducting regular evaluations, maintaining ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 ... China Chitosan Industry” is a professional and ... market. The report provides basic Chitosan information, ... chain structure as well as industry overview. ... China’s domestic market as well as global ...
(Date:7/30/2014)... -- For patients with asthma, just believing an odor ... for at least 24 hours, a new study indicates. ... what you think you smell," study author Cristina Jaen, ... said in a Monell news release. "Asthmatics ... expect that an odor is harmful, our bodies react ...
(Date:7/30/2014)... the many sub-groups of cells jockeying for supremacy within ... those that can proliferate the fastest, researchers at Dana-Farber ... advance online publication of the journal Nature . ... of cancer with precision medicines, the study authors explained: ... driving the tumor,s growth and metastasis and select drugs ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 2Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 3Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 4Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 3Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 2Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 3Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 4Health News:Even Thinking an Odor is Harmful May Spur Asthma Symptoms 2Health News:Target growth-driving cells within tumors, not fastest-proliferating cells 2Health News:Target growth-driving cells within tumors, not fastest-proliferating cells 3
... safer glucocorticoid drugs , Glucocorticoid drugs are ... allergic reactions, asthma, and some forms of cancer, and ... their potent antiinflammatory and immunosuppressive properties. However, their long-term ... blood levels of glucose, fatty liver, and type 2 ...
... , This release is available in French ... and the brain appear to be even more closely connected ... apparently not confined to the heart, but also affect the ... the level of the brainstem, which leads to insomnia, notably ...
... be the victim of a snakebite, the best thing you ... possible, according to a new review article from the ... Current medical treatments, including new medications and surgery, if necessary, ... do on your own. , "Previous generations of antivenin medications ...
... risk of prostate cancer, a new study published today in the ... led by The University of Warwick and The Institute of Cancer ... ring finger were one third less likely to develop the disease ... show that relative finger length could be used as a simple ...
... 2010 Elsevier, the leading publisher of scientific, technical ... availability of Case Reviews Online, an online edition of ... for board review. The Case Reviews Online ... board preparation needs. Detailed cases, including 4-10 images ...
... Eating a diet rich in omega-3 fatty acids appears to ... known as age-related macular degeneration (AMD), a new analysis indicates. ... and shellfish may protect against advanced AMD," study lead author ... Hopkins School of Medicine in Baltimore, said in a news ...
Cached Medicine News:Health News:JCI online early table of contents: Dec. 1, 2010 2Health News:JCI online early table of contents: Dec. 1, 2010 3Health News:JCI online early table of contents: Dec. 1, 2010 4Health News:JCI online early table of contents: Dec. 1, 2010 5Health News:JCI online early table of contents: Dec. 1, 2010 6Health News:JCI online early table of contents: Dec. 1, 2010 7Health News:JCI online early table of contents: Dec. 1, 2010 8Health News:JCI online early table of contents: Dec. 1, 2010 9Health News:JCI online early table of contents: Dec. 1, 2010 10Health News:Insomnia after myocardial infarction 2Health News:What to do if you are bitten by a snake 2Health News:Finger length points to prostate cancer risk 2Health News:Elsevier launches innovative online radiology board review product 2Health News:Can Omega-3 Foods Prevent Eye Disease in Seniors? 2
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... YORK , July 30, 2014 ACCESS ... for oncology supportive care, announced that its novel product ... in an article on OncLive.com titled, "Study Finds Mouth ... Cancers."  Dr. Steve Sonis , a leading expert ... seen in the oncology community for evidence-based strategies for ...
(Date:7/30/2014)... , July 30, 2014   Bluegrass ... focused on innovating lifesaving devices and methods for ... million in Series A financing, which was led ... from the deal will allow Bluegrass Vascular to ... Catheter System, enhance manufacturing capabilities, and proceed with ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds 2
... Dilon expands its portfolio of breast imaging solutions ... Mammography Information System technology by KLAS for three ... loyalty are the foundation of PenRad,s success. Together ... and an information management system that significantly improves ...
... Hurricane Irene came rushing up the East Coast as a ... United States, many states in the Northeast began to worry. The ... hurricanes. Coastal towns from New Jersey all the way up to ... City was one that took steps that had not been seen ...
Cached Medicine Technology:Dilon Diagnostics® Partners With PenRad® 2Dilon Diagnostics® Partners With PenRad® 3Hospitals Evacuated in Preparation for Hurricane Irene with Aid of Pulse Oximeter 2
... parafollicular C-cells of the thyroid gland and ... action of calcitonin is to lower plasma ... in decreased mobilization of calcium from bone ... conditions associated with high levels of bone ...
Calcitonin RIA Kit...
... The Matrix Perimeter utilizes Welch ... a significant breakthrough in visual field ... capabilities, tools to characterize glaucoma and ... Humphrey FDT Perimeter, the Matrix doubles ...
... digital camera system by KARL STORZ, a ... camera systems. Digital Source Sampling technology, applied ... fully digital transfer of information with no ... as well as loss-free data storage on ...
Medicine Products: